486 related articles for article (PubMed ID: 14597787)
1. Can we prevent Parkinson's and Alzheimer's disease?
Kedar NP
J Postgrad Med; 2003; 49(3):236-45. PubMed ID: 14597787
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
Behl C; Holsboer F
Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
[TBL] [Abstract][Full Text] [Related]
3. Ingredients for functional drinks in neurodegenerative diseases: a review.
Zafrilla P; Morillas JM; Rubio-Perez JM; Cantos Villar E
Nat Prod Commun; 2009 May; 4(5):719-40. PubMed ID: 19445320
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein, Parkinson's disease, and Alzheimer's disease.
Kim S; Seo JH; Suh YH
Parkinsonism Relat Disord; 2004 May; 10 Suppl 1():S9-13. PubMed ID: 15109581
[TBL] [Abstract][Full Text] [Related]
5. Neurochemical abnormalities in Alzheimer's disease and Parkinson's disease--a comparative review.
Gsell W; Strein I; Krause U; Riederer P
J Neural Transm Suppl; 1997; 51():145-59. PubMed ID: 9470135
[TBL] [Abstract][Full Text] [Related]
6. Multiple antioxidants in the prevention and treatment of neurodegenerative disease: analysis of biologic rationale.
Prasad KN; Cole WC; Hovland AR; Prasad KC; Nahreini P; Kumar B; Edwards-Prasad J; Andreatta CP
Curr Opin Neurol; 1999 Dec; 12(6):761-70. PubMed ID: 10676761
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
Praticò D
Trends Pharmacol Sci; 2008 Dec; 29(12):609-15. PubMed ID: 18838179
[TBL] [Abstract][Full Text] [Related]
8. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows.
Praticò D
Ann N Y Acad Sci; 2008 Dec; 1147():70-8. PubMed ID: 19076432
[TBL] [Abstract][Full Text] [Related]
9. Why do Alzheimer's disease and Parkinson's disease target the same neurons?
Eggers AE
Med Hypotheses; 2009 Jun; 72(6):698-700. PubMed ID: 19250756
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation on the disability weight of Alzheimer's disease and Parkinson's disease in Beijing].
Duan LL; Zhang ZX; Huang JB; Hong X; Wen HB; Wang QH; Li H
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Mar; 24(3):220-3. PubMed ID: 12816717
[TBL] [Abstract][Full Text] [Related]
12. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition.
Steele M; Stuchbury G; Münch G
Exp Gerontol; 2007; 42(1-2):28-36. PubMed ID: 16839733
[TBL] [Abstract][Full Text] [Related]
13. [Biology of thioredoxin and its association with Alzheimer's disease and Parkinson's disease].
Li LB; Liu GT
Yao Xue Xue Bao; 2008 Jan; 43(1):1-8. PubMed ID: 18357724
[TBL] [Abstract][Full Text] [Related]
14. Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Papapetropoulos S; Lieberman A; Gonzalez J; Mash DC
Acta Neurol Scand; 2005 Jun; 111(6):353-9. PubMed ID: 15876335
[TBL] [Abstract][Full Text] [Related]
15. Treatment possibilities of Alzheimer's disease.
Miklya I; Gaszner P
Neuropsychopharmacol Hung; 2004 Dec; 6(4):200-9. PubMed ID: 15825676
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant strategies for Alzheimer's disease.
Grundman M; Grundman M; Delaney P
Proc Nutr Soc; 2002 May; 61(2):191-202. PubMed ID: 12133201
[TBL] [Abstract][Full Text] [Related]
18. Multimodal drugs and their future for Alzheimer's and Parkinson's disease.
Van der Schyf CJ; Geldenhuys WJ
Int Rev Neurobiol; 2011; 100():107-25. PubMed ID: 21971005
[TBL] [Abstract][Full Text] [Related]
19. Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases.
Migliore L; Fontana I; Colognato R; Coppede F; Siciliano G; Murri L
Neurobiol Aging; 2005 May; 26(5):587-95. PubMed ID: 15708433
[TBL] [Abstract][Full Text] [Related]
20. A review of antioxidants and Alzheimer's disease.
Frank B; Gupta S
Ann Clin Psychiatry; 2005; 17(4):269-86. PubMed ID: 16402761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
